NCT04939025

Brief Summary

The objective of this quality improvement project is to increase the one year anastomotic integrity rate in patients having had completion proctectomy and pouch reconstruction for Ulcerative Colitis by the routine and quality controlled implementation of a multi-interventional program thereby improving long-term pouch function and survival.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2021

Longer than P75 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 23, 2021

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 25, 2021

Completed
6 days until next milestone

Study Start

First participant enrolled

July 1, 2021

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2022

Completed
3.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2025

Completed
Last Updated

June 25, 2021

Status Verified

June 1, 2021

Enrollment Period

1 year

First QC Date

June 23, 2021

Last Update Submit

June 23, 2021

Conditions

Keywords

ileoanal pouch, IPAA, pouch, ulcerative colitis, leak

Outcome Measures

Primary Outcomes (1)

  • Leak rate

    Anastomotic integrity at one year postoperatively defined as the absence of presacral collections, anastomotic fistula and severe anastomotic stricture (not amenable for digital dilatation by rectal exam).

    1 year

Secondary Outcomes (14)

  • Cumulative anastomotic dehiscence rate

    18 month

  • QOL

    3,6,12 and 18 months

  • Protocol compliance

    18 month

  • ICG

    Operative

  • CRP

    30 days

  • +9 more secondary outcomes

Study Arms (2)

Historic cohort

NO INTERVENTION

Multi-interventional program cohort

OTHER
Procedure: Multi-interventional program

Interventions

1. Preoperative oral antibiotics and antibiotic enema of the rectal stump prior to the surgery 2. Routine and tailored lengthening measures of the mesentery 3. Intraoperative control of pouch vascularization using ICG 4. Early diagnosis and active assessment of the integrity of the anastomosis. 1. Routine CRP-measurements at day 4 and 6 (after removal pouch catheter) in the non-diverted pouches with CT-scan with rectal contrast if any suspicion on a leak (elevated or rise in CRP. symptoms). 2. Routine CRP-measurements at day 4 in the diverted pouches with endoscopy 10-14 days after pouch creation. 5. Endosponge vacuum assisted closure (EVAC) of the anastomotic defect aiming to close the defect within 10-14 days after diagnosis. 6. MRI assessment of the pouch after stoma closure preferably at one year to rule out chronic sepsis mimicking pouchitis or Crohn's disease.

Multi-interventional program cohort

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of Ulcerative Colitis
  • Diagnosis of Crohn's disease limited to the colon without any history of perianal disease
  • Modified two or three stage restorative proctocolectomy
  • Age above 18
  • Able to fill in questionnaires in local language and to come to out-patient-clinic visits;

You may not qualify if:

  • Known allergy to ICG, or iodide allergy.
  • Pregnancy
  • Redo pouch operation
  • Age under 18

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Colitis, Ulcerative

Condition Hierarchy (Ancestors)

ColitisGastroenteritisGastrointestinal DiseasesDigestive System DiseasesInflammatory Bowel DiseasesColonic DiseasesIntestinal Diseases

Central Study Contacts

Mohammed Deputy

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
SEQUENTIAL
Model Details: The MIRACLE study is an international multicenter clinical effectiveness study, whereby the current local practice (control cohort) will be evaluated, and subsequently compared to the results after implementation of the multi-interventional program (intervention cohort).
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 23, 2021

First Posted

June 25, 2021

Study Start

July 1, 2021

Primary Completion

July 1, 2022

Study Completion

August 1, 2025

Last Updated

June 25, 2021

Record last verified: 2021-06